Kvalitet života žena operisanih od karcinoma dojke u Crnoj Gori
Sažetak
Uvod/Cilj: Karcinom dojke je česta maligna bolest na Balkanu. Cilj rada je bio utvrditi da li postoje razlike u parametrima percepcije zdravlja i kvaliteta života među crnogorskim pacijentkinjama nakon operacija, radioterapije i hemioterapije zbog karcinoma dojke. Pomenuti ishodi su ispitivani u odnosu na uzrast, vrstu tretmana i stava prema preventivnim dijagnostičkim merama.
Metode: Istraživanje je sprovedeno na uzorku od 200 žena sa karcinomom dojke lečenim u zdravstvenim ustanovama u Crnoj Gori. Autentično dizajnirani upitnik baziran na tri prethodno dizajnirana upitnika (Functional Assesment of Cancer Therapy: General (FACT-G), njegova vrsta specifična za karcinom dojke (FACT-B), kao i instrument dizajniran od strane Evropske organizacije za istraživanje i lečenje raka (EORTC-QLQ C30)) je korišten.
Rezultati: Najniži kvalitet života je nađen u pacijenktinjama starosti 60 – 64 godine. Pacijentkinje su često navodile da se osećaju tužno, da gube nadu ili da brinu da će neko iz njihove porodice oboleti od raka dojke. Kvalitet života je bio niži među pacijentkinjama koje su navele da ne razumeju svoju bolest dobro.
Zaključak: Ovi rezultati treba da inspirišu kliničare da edukuju svoje pacijente i pruže im psihološku podršku u toku lečenja.
Reference
Carelle N, Piotto E, Bellanger A, Germanaud J, Thuillier A, Khayat D. Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 2002; 95(1):155-63. [CrossRef] [PubMed]
Carioli G, Malvezzi M, Rodriguez T, Bertuccio P, Negri E, La Vecchia C. Trends and predictions to 2020 in breast cancer mortality in Europe. Breast 2017;36: 89-95. [CrossRef] [PubMed]
Costa WA, Eleutério J Jr, Giraldo PC, Gonçalves AK. Quality of life in breast cancer survivors. Rev Assoc Med Bras 2017;63(7):583-9. [CrossRef] [PubMed]
Cummins RA. Personal income and subjective well-being: a review. J Happiness Stud 2000;1:133-58. [CrossRef]
Dialla PO, Chu WO, Roignot P, Bone-Lepinoy MC, Poillot ML, Coutant C, et al. Impact of age-related socio-economic and clinical determinants of quality of life among long-term breast cancer survivors. Matu-ritas 2015;81(3):362-70. [CrossRef] [PubMed]
Dimitrova N, Znaor A, Agius D, Eser S, Sekerija M, Ryzhov A, et al. Breast cancer in South-Eastern European countries since 2000: Rising incidence and decreasing mortality at young and middle ages. Eur J Cancer 2017;83:43-55. [CrossRef] [PubMed]
Engqvist Boman L, Sandelin K, Wengström Y, Silén C. Patients' learning and understanding during their breast cancer trajectory. Patient Educ Couns 2017; 100(5):795-804. [CrossRef] [PubMed]
Hamer J, McDonald R, Zhang L, Verma S, Leahey A, Ecclestone C, et al. Quality of life (QOL) and symptom burden (SB) in patients with breast cancer. Support Care Cancer 2017;25(2):409-19.[CrossRef] [PubMed]
Hsu T, Ennis M, Hood N, Graham M, Goodwin PJ. Quality of life in long-term breast cancer survivors. J Clin Oncol 2013;31(28):3540-8. [CrossRef] [PubMed]
Kamińska M, Ciszewski T, Kukiełka-Budny B, Kubiatowski T, Baczewska B, Makara-Studzińska M, et al. Life quality of women with breast cancer after mastectomy or breast conserving therapy treated with adjuvant chemotherapy. Ann Agric Environ Med 2015; 22(4):724-30. [CrossRef] [PubMed]
Kelsey JL, Bernstein L. Epidemiology and prevention of breast cancer. Annu Rev Public Health 1996;17:47-67. [CrossRef] [PubMed]
Marino JL, Saunders CM, Emery LI, Green H, Doherty DA, Hickey M. How does adjuvant chemotherapy affect menopausal symptoms, sexual function, and quality of life after breast cancer? Menopause 2016; 23(9):1000-8. [CrossRef] [PubMed]
Namkoong K, McLaughlin B, Yoo W, Hull SJ, Shah DV, Kim SC, et al. The effects of expression: how pro-viding emotional support online improves cancer pa-tients' coping strategies. J Natl Cancer Inst Monogr 2013;(47):169-74. [CrossRef] [PubMed]
Tiezzi MF, de Andrade JM, Romão AP, Tiezzi DG, Lerri MR, Carrara HA, et al. Quality of Life in Women With Breast Cancer Treated With or Without Chemo-therapy. Cancer Nurs 2017;40(2):108-16. [CrossRef] [PubMed]